Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring-Reference-Cited by-同舟云学术

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring

Published:2017-06 Issue:3 Volume:39 Page:235-242
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Kozo Daniel,Ross Matt W.,Jarrah Justin,Barrett Michael,Harney Rebecca L.,Courtney Jodi B.,Baburina Irina,Holleran Julianne L.,Beumer Jan H.,Peters Godefridus J.,Honeywell Richard J.,Salamone Salvatore J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. A Role of body surface area in dosing of investigational anticancer agents in adults, 1991–2001;Baker;J Natl Cancer Inst.,2002

2. Dosing strategies for anticancer drugs: the good, the bad and body-surface area;Felici;Eur J Cancer.,2002

3. Novel developments in the use of antimetabolites;Peters;Nucleosides Nucleotides Nucleic Acids.,2014

4. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer;Sandler;J Clin Oncol.,2000

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol.,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Simple and Reliable HPLC-UV Method for Determining Gemcitabine Levels: Application in Pharmacokinetic Analysis;Medicina;2024-05-25

2. Development of a UPLC–MS/MS method for simultaneous therapeutic drug monitoring of anti-hepatocellular carcinoma drugs and analgesics in human plasma;Frontiers in Pharmacology;2023-05-31

3. Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug discovery;Cytotechnology;2022-10-20

4. Development of an agglutination-enhancement immunoturbidimetric tacrolimus assay with improved sensitivity;Journal of Pharmaceutical and Biomedical Analysis;2021-10

5. Phase I study of veliparib in combination with gemcitabine;Cancer Chemotherapy and Pharmacology;2017-08-02